Literature DB >> 20683618

Similar renal outcomes in children with ADPKD diagnosed by screening or presenting with symptoms.

Djalila Mekahli1, Adrian S Woolf, Detlef Bockenhauer.   

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) in children is sometimes considered to be a benign condition, with morbidity manifesting in adulthood. Therefore, diagnostic screening of children at risk is controversial. The aim of our study was to to compare the manifestations of ADPKD in children diagnosed by postnatal ultrasound (US) screening versus those presenting with symptoms. This was a retrospective chart review of children with ADPKD assessed in a single centre between 1987 and 2007. Age and reason for diagnosis were noted, and children were separated into two groups: (1) those diagnosed on the basis of family-based screening; (2) those presenting with a symptom. The two groups were compared for renal size, number of cysts, estimated glomerular filtration rate (eGFR), the presence of hypertension and microalbuminuria. In the 47 children with ADPKD (21 females) from 33 families who satisfied the enrollment criteria, mean (standard deviation) age at referral and last follow-up was 7.2 (4.4) and 12.9 (5.1) years, respectively, and the mean follow-up duration was 5.7 (3.6) years. Diagnosis was based on postnatal US screening in 31 children, whereas 16 were diagnosed after presenting with symptoms. The proportions of children with nephromegaly, hypertension, microalbuminuria and decreased eGFR, respectively, were similar in both groups. Based on these results, we conclude that renal-related morbidities, including hypertension and microalbuminia, do occur in children with ADPKD and at a similar frequency in those diagnosed after presenting with symptoms and those diagnosed upon postnatal screening. We suggest that at-risk children should have regular checks to detect hypertension. Moreover, affected children may benefit from novel therapies to minimise cystic disease progression.

Entities:  

Mesh:

Year:  2010        PMID: 20683618     DOI: 10.1007/s00467-010-1617-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  44 in total

1.  Kidney disease in hypomelanosis of Ito.

Authors:  R J Coward; R A Risdon; C Bingham; A T Hattersley; A S Woolf
Journal:  Nephrol Dial Transplant       Date:  2001-06       Impact factor: 5.992

Review 2.  Prenatal diagnosis of autosomal dominant polycystic kidney disease (PKD1) presenting in utero and prognosis for very early onset disease.

Authors:  K D MacDermot; A K Saggar-Malik; D L Economides; S Jeffery
Journal:  J Med Genet       Date:  1998-01       Impact factor: 6.318

3.  Oral-facial-digital syndrome type 1 is another dominant polycystic kidney disease: clinical, radiological and histopathological features of a new kindred.

Authors:  S A Feather; P J Winyard; S Dodd; A S Woolf
Journal:  Nephrol Dial Transplant       Date:  1997-07       Impact factor: 5.992

4.  Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population.

Authors:  Catherine L Kelleher; Kim K McFann; Ann M Johnson; Robert W Schrier
Journal:  Am J Hypertens       Date:  2004-11       Impact factor: 2.689

Review 5.  Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.

Authors:  Robert W Schrier
Journal:  J Am Soc Nephrol       Date:  2009-08-20       Impact factor: 10.121

Review 6.  Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and treatment.

Authors:  Ming-Yang Chang; Albert C M Ong
Journal:  Nephron Physiol       Date:  2007-12-13

7.  Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial.

Authors:  Loes van Keimpema; Frederik Nevens; Ragna Vanslembrouck; Martijn G H van Oijen; Aswin L Hoffmann; Helena M Dekker; Robert A de Man; Joost P H Drenth
Journal:  Gastroenterology       Date:  2009-07-29       Impact factor: 22.682

8.  Childhood onset autosomal dominant polycystic kidney disease in sibs: clinical picture and recurrence risk. German Working Group on Paediatric Nephrology (Arbeitsgemeinschaft für Pädiatrische Nephrologie.

Authors:  K Zerres; S Rudnik-Schöneborn; F Deget
Journal:  J Med Genet       Date:  1993-07       Impact factor: 6.318

9.  Unified criteria for ultrasonographic diagnosis of ADPKD.

Authors:  York Pei; James Obaji; Annie Dupuis; Andrew D Paterson; Riccardo Magistroni; Elizabeth Dicks; Patrick Parfrey; Benvon Cramer; Eliecer Coto; Roser Torra; Jose L San Millan; Robert Gibson; Martijn Breuning; Dorien Peters; David Ravine
Journal:  J Am Soc Nephrol       Date:  2008-10-22       Impact factor: 10.121

10.  Genotype-phenotype correlation in children with autosomal dominant polycystic kidney disease.

Authors:  Filip Fencl; Jan Janda; Kveta Bláhová; Zdenek Hríbal; Jitka Stekrová; Alena Puchmajerová; Tomás Seeman
Journal:  Pediatr Nephrol       Date:  2009-02-05       Impact factor: 3.714

View more
  15 in total

Review 1.  Genetic testing in renal disease.

Authors:  Detlef Bockenhauer; Alan J Medlar; Emma Ashton; Robert Kleta; Nick Lench
Journal:  Pediatr Nephrol       Date:  2011-05-27       Impact factor: 3.714

Review 2.  Liver involvement in kidney disease and vice versa.

Authors:  Karen Van Hoeve; Djalila Mekahli; Eva Morava; Elena Levtchenko; Peter Witters
Journal:  Pediatr Nephrol       Date:  2017-06-23       Impact factor: 3.714

Review 3.  Angiogenesis and autosomal dominant polycystic kidney disease.

Authors:  Jennifer L Huang; Adrian S Woolf; David A Long
Journal:  Pediatr Nephrol       Date:  2012-09-19       Impact factor: 3.714

4.  Early renal abnormalities in children with postnatally diagnosed autosomal dominant polycystic kidney disease.

Authors:  Luciano Selistre; Vandréa de Souza; Bruno Ranchin; Aoumeur Hadj-Aissa; Pierre Cochat; Laurence Dubourg
Journal:  Pediatr Nephrol       Date:  2012-06-12       Impact factor: 3.714

5.  Prevalence of Hypertension in Children with Early-Stage ADPKD.

Authors:  Laura Massella; Djalila Mekahli; Dušan Paripović; Larisa Prikhodina; Nathalie Godefroid; Anna Niemirska; Ayşe Ağbaş; Karolina Kalicka; Augustina Jankauskiene; Malgorzata Mizerska-Wasiak; Alberto Caldas Afonso; Rémi Salomon; Georges Deschênes; Gema Ariceta; Z Birsin Özçakar; Ana Teixeira; Ali Duzova; Jérôme Harambat; Tomáš Seeman; Gabriela Hrčková; Adrian Catalin Lungu; Svetlana Papizh; Amira Peco-Antic; Stéphanie De Rechter; Ugo Giordano; Marietta Kirchner; Teresa Lutz; Franz Schaefer; Olivier Devuyst; Elke Wühl; Francesco Emma
Journal:  Clin J Am Soc Nephrol       Date:  2018-04-19       Impact factor: 8.237

Review 6.  From bone abnormalities to mineral metabolism dysregulation in autosomal dominant polycystic kidney disease.

Authors:  Djalila Mekahli; Justine Bacchetta
Journal:  Pediatr Nephrol       Date:  2013-01-24       Impact factor: 3.714

7.  Oxidative stress in autosomal dominant polycystic kidney disease: player and/or early predictor for disease progression?

Authors:  Asmin Andries; Kristien Daenen; François Jouret; Bert Bammens; Djalila Mekahli; Ann Van Schepdael
Journal:  Pediatr Nephrol       Date:  2018-08-13       Impact factor: 3.714

Review 8.  Tolvaptan in Pediatric Autosomal Dominant Polycystic Kidney Disease: From Here to Where?

Authors:  Fei Liu; Chunyue Feng; Huijun Shen; Huaidong Fu; Jianhua Mao
Journal:  Kidney Dis (Basel)       Date:  2021-07-02

Review 9.  Cystic kidney diseases: many ways to form a cyst.

Authors:  Hannah Loftus; Albert C M Ong
Journal:  Pediatr Nephrol       Date:  2012-06-27       Impact factor: 3.714

Review 10.  Predictors of progression in autosomal dominant and autosomal recessive polycystic kidney disease.

Authors:  Eric G Benz; Erum A Hartung
Journal:  Pediatr Nephrol       Date:  2021-01-21       Impact factor: 3.651

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.